Transforming growth factor beta
Transforming Growth Factor Beta[edit]

Transforming Growth Factor Beta (TGF-_) is a multifunctional peptide that controls proliferation, cellular differentiation, and other functions in most cells. It belongs to the transforming growth factor beta superfamily of cytokines.
Structure[edit]
TGF-_ is a secreted protein that exists in three isoforms in mammals: TGF-_1, TGF-_2, and TGF-_3. These isoforms are encoded by separate genes and are highly conserved across species. The active form of TGF-_ is a dimeric protein that is stabilized by a disulfide bond.
Function[edit]
TGF-_ plays a crucial role in cellular processes such as cell growth, apoptosis, and cellular differentiation. It is involved in the regulation of the immune system, wound healing, and embryonic development. TGF-_ signaling is initiated when the ligand binds to a type II receptor, which then recruits and phosphorylates a type I receptor. This receptor complex then phosphorylates receptor-regulated SMADs (R-SMADs), which translocate to the nucleus to regulate gene expression.

Signaling Pathway[edit]
The TGF-_ signaling pathway involves several key components, including the TGF-_ receptors, SMAD proteins, and various co-factors. Upon ligand binding, the type II receptor phosphorylates the type I receptor, which in turn phosphorylates R-SMADs. These R-SMADs form a complex with co-SMADs and translocate to the nucleus to regulate target gene expression.
Role in Disease[edit]
TGF-_ is implicated in various diseases, including cancer, fibrosis, and autoimmune disorders. In cancer, TGF-_ can act as both a tumor suppressor and a tumor promoter, depending on the context. It is known to inhibit the early stages of tumor development but can promote tumor progression and metastasis in later stages.
Therapeutic Applications[edit]
Due to its involvement in numerous pathological conditions, TGF-_ is a target for therapeutic intervention. Strategies include the use of TGF-_ inhibitors, receptor blockers, and antisense oligonucleotides to modulate its activity in diseases such as cancer and fibrosis.

Related Pages[edit]
References[edit]
-
Transforming growth factor beta
-
SMAD apoptosis pathway
-
DAXX Pathway
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian